Neoadjuvant Erlotinib Treatment in Patients with Resectable Non-Small Cell Lung Carcinoma

被引：0
作者：
Van Gool, Matthijs [1 ]
Kiomp, Houke [1 ]
机构：
[1] NKI AVL, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
neoadjuvant; Surgery; EGFR-TKI;
D O I：
10.1016/j.jtho.2016.11.834
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.05-049
引用
收藏
页码：S644 / S645
页数：2
相关论文
共 50 条
  • [31] The Effectiveness of Erlotinib Against Brain Metastases in Non-Small Cell Lung Cancer Patients
    Bai, Hao
    Han, Baohui
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (02): : 110 - 115
  • [32] Neoadjuvant Pembrolizumab for Early Stage Non-Small Cell Lung Cancer
    Bar, J.
    Urban, D.
    Redinsky, I.
    Ackerstein, A.
    Daher, S.
    Kamer, I.
    Onn, A.
    Shulimzon, T.
    Peled, M.
    Zeitlin, N.
    Kremer, R.
    Raskin, S.
    Ben-Nun, A.
    Perelman, M.
    Ofek, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S865 - S866
  • [33] Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer
    Stiles, Brendon M.
    Sepesi, Boris
    Broderick, Stephen R.
    Bott, Matthew J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 160 (05) : 1376 - 1382
  • [34] Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art
    Kang, Jin
    Zhang, Chao
    Zhong, Wen-Zhao
    CANCER COMMUNICATIONS, 2021, 41 (04) : 287 - 302
  • [35] Neoadjuvant chemoradiation in non-small cell lung cancer
    Girard, N.
    Hennequin, C.
    Mornex, F.
    ONCOLOGIE, 2007, 9 (06) : 475 - 481
  • [36] The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer
    Guven, Deniz Can
    Sahin, Taha Koray
    Kilickap, Saadettin
    CANCERS, 2024, 16 (01)
  • [37] Neoadjuvant immunotherapy for advanced, resectable non-small cell lung cancer: A systematic review and meta-analysis
    Wu, Yajing
    Verma, Vivek
    Gay, Carl M.
    Chen, Yujia
    Liang, Fei
    Lin, Qiang
    Wang, Jianing
    Zhang, Wei
    Hui, Zhouguang
    Zhao, Min
    Wang, Jun
    Chang, Joe Y.
    CANCER, 2023, 129 (13) : 1969 - 1985
  • [38] Toripalimab and Platinum-Doublet Chemotherapy as Neoadjuvant Therapy for Potentially Resectable Non-Small Cell Lung Cancer
    Zhang, Y.
    Zeng, L.
    Zhang, X.
    Zhou, Y.
    Zhang, B.
    Jiang, W.
    Yang, N.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1014 - S1015
  • [39] Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Non-Small Cell Lung Cancer
    Li, N.
    Ying, J.
    Tao, X.
    Zhang, F.
    Zhao, Z.
    Ling, Y.
    Gao, Y.
    Zhao, J.
    Xue, Q.
    Mao, Y.
    Lei, W.
    Wu, N.
    Wang, S.
    Duan, J.
    Gao, Y.
    Wang, Z.
    Sun, N.
    Wang, J.
    Gao, S.
    He, J.
    Zhou, H.
    Wang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S627 - S628
  • [40] A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
    Cascone, Tina
    Sepesi, Boris
    Lin, Heather Y.
    Kalhor, Neda
    Parra, Edwin R.
    Jiang, Mei
    Godoy, Myrna C. B.
    Zhang, Jianjun
    Fossella, Frank, V
    Tsao, Anne S.
    Lam, Vincent K.
    Lu, Charles
    Mott, Frank E.
    Simon, George R.
    Antonoff, Mara B.
    Mehran, Reza J.
    Rice, David C.
    Behrens, Carmen
    Weissferdt, Annikka
    Moran, Cesar
    Vaporciyan, Ara A.
    Lee, J. Jack
    Swisher, Stephen G.
    Gibbons, Don L.
    Wistuba, Ignacio I.
    William, William N., Jr.
    Heymach, John, V
    CLINICAL CANCER RESEARCH, 2020, 26 (14) : 3525 - 3536
12345